CMS might reconsider a decision to allow broad Medicare coverage of drug-coated stents because of concerns that the devices can increase risk for blood clots.
According to a CMS spokesperson, the agency might restrict Medicare coverage of drug-coated stents to uses approved by FDA, place some restrictions on coverage or maintain current coverage. Medicare in 2005 paid about $14.7 billion for surgeries to implant drug-coated stents.
- « Health Plan :: Edwards releases universal health coverage plan
- Depression :: Cyberonics request rejected for Medicare coverage of vagus nerve stimulator for depression »
Sub-editorStent :: CMS reconsiders to allow broad Medicare coverage of drug-coated stents
by Sub-editor ( Author at Spirit India )
Posted on February 6th, 2007 at 1:23 pm.
Find more from SpiritIndia on: Health